Acheson, Liam S., Clay, Simon, Ezard, Nadine, Siefried, Krista J., McKetin, Rebecca, Lintzeris, Nicholas, Dunlop, Adrian, Brett, Jonathan, Christmass, Michael, Rodgers, Craig, Shoptaw, Steve, Farrell, Michael. Elsevier; 2024. Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention.

Farrell, Michael, Shahbazi, Jeyran, Byrne, Marianne, Grebely, Jason, Lintzeris, Nicholas, Chambers, Mark, Larance, Briony, Ali, Robert, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Nicholas, Thomas, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa. Elsevier; 2022. Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence.

Farrell, Michael, Shahbazi, Jeyran, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa, Chambers, Mark, Byrne, Marianne, Gholami, Jaleh, Zahra, Emma, Grebely, Jason, Lintzeris, Nicholas, Larance, Briony, Ali, Robert. Elsevier; 2024. 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.

Acheson, Liam S., Ezard, Nadine, Shoptaw, Steve, Siefried, Krista J., Lintzeris, Nicholas, Dunlop, Adrian, Brett, Jonathan, Rodgers, Craig, Gill, Anthony, Christmass, Michael, McKetin, Rebecca, Farrell, Michael. Elsevier; 2022. Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial.

Settumba, Stella, Shahbazi, Jeyran, Blazey, Alison, Weiss, Robert, Dunlop, Adrian, McDonough, Michael, Cook, Jon, Farrell, Michael, Byrne, Marianne, Degenhardt, Louisa, Grebely, Jason, Larance, Briony, Nielsen, Suzanne, Lintzeris, Nicholas, Ali, Robert, Rodgers, Craig. Wiley-Blackwell; 2025. Provider costs of treating opioid dependence with extended-release buprenorphine in Australia.